Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Nagarajah, J."" wg kryterium: Autor


Tytuł :
Effect of Kinase Inhibitors on the Technetium-99m Uptake into Thyroid Carcinoma Cells In Vitro .
Autorzy :
Anschlag A; Department of Child and Adolescent Psychiatry, University Hospital of Marburg, Marburg, Germany; .
Greene BH; Bio 21 Institute, CSL Limited Melbourne, Parkville, VIC, Australia.
KÖnneker L; Department of Virology, Hospital Nordwest Frankfurt, Frankfurt, Germany.
Luster M; Department of Nuclear Medicine, University Hospital of Marburg, Marburg, Germany.
Nagarajah J; Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
WÄchter S; Department of Visceral, Thoracic and Vascular Surgery, University Hospital of Marburg, Marburg, Germany.
Wunderlich A; Department of Visceral, Thoracic and Vascular Surgery, University Hospital of Marburg, Marburg, Germany.
Pfestroff A; Department of Nuclear Medicine, University Hospital of Marburg, Marburg, Germany.
Pokaż więcej
Źródło :
In vivo (Athens, Greece) [In Vivo] 2021 Mar-Apr; Vol. 35 (2), pp. 721-729.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non-medullary thyroid cancer.
Autorzy :
Crezee T; Department of Pathology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 10, Nijmegen, 6500 HB, The Netherlands. .
Tesselaar MH; Department of Pathology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 10, Nijmegen, 6500 HB, The Netherlands.
Nagarajah J; Department of Radiology & Nuclear Medicine, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Corver WE; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Morreau J; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Pritchard C; Department of Pathology, University of Leicester, Leicester, LEI7RH, UK.
Kimura S; Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Kuiper JG; PHARMO Institute, Utrecht, The Netherlands.
van Engen-van Grunsven I; Department of Pathology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 10, Nijmegen, 6500 HB, The Netherlands.
Smit JWA; Department of Internal Medicine, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Netea-Maier RT; Department of Internal Medicine, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Plantinga TS; Department of Pathology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 10, Nijmegen, 6500 HB, The Netherlands.
Pokaż więcej
Źródło :
Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2021 Feb 03. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Head-to-head comparison of Ga-prostate-specific membrane antigen PET/CT and ferumoxtran-10 enhanced MRI for the diagnosis of lymph node metastases in prostate cancer patients.
Autorzy :
Schilham MG; Radboudumc Nijmegen, Netherlands.
Zamecnik P; Radboud University Medical Centre, Netherlands.
Privé BM; Radboud University Medical Centre, Netherlands.
Israël B; Radboud University Medical Centre, Netherlands.
Rijpkema M; Radboud University Medical Center.
Scheenen T; Radboud University Medical Centre, Netherlands.
Barentsz JO; Radboud University Medical Centre, Netherlands.
Nagarajah J; Radboud University Medical Centre, Netherlands.
Gotthardt M; Radboud University Medical Center.
Pokaż więcej
Źródło :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2021 Jan 30. Date of Electronic Publication: 2021 Jan 30.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with Ac-PSMA-617 targeted alpha-radiation therapy.
Autorzy :
van der Doelen MJ; Radboud University Medical Center, Department of Medical Oncology, Nijmegen, The Netherlands; Radboud University Medical Center, Department of Urology, Nijmegen, The Netherlands. Electronic address: .
Mehra N; Radboud University Medical Center, Department of Medical Oncology, Nijmegen, The Netherlands.
van Oort IM; Radboud University Medical Center, Department of Urology, Nijmegen, The Netherlands.
Looijen-Salamon MG; Radboud University Medical Center, Department of Pathology, Nijmegen, The Netherlands.
Janssen MJR; Radboud University Medical Center, Department of Radiology and Nuclear Medicine, Nijmegen, The Netherlands.
Custers JAE; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Medical Psychology, Nijmegen, The Netherlands.
Slootbeek PHJ; Radboud University Medical Center, Department of Medical Oncology, Nijmegen, The Netherlands.
Kroeze LI; Radboud University Medical Center, Department of Pathology, Nijmegen, The Netherlands.
Bruchertseifer F; European Commission, Joint Research Centre, Nuclear Safety and Security, Karlsruhe, Germany.
Morgenstern A; European Commission, Joint Research Centre, Nuclear Safety and Security, Karlsruhe, Germany.
Haberkorn U; University Hospital Heidelberg, Department of Nuclear Medicine, Germany.
Kratochwil C; University Hospital Heidelberg, Department of Nuclear Medicine, Germany.
Nagarajah J; Radboud University Medical Center, Department of Radiology and Nuclear Medicine, Nijmegen, The Netherlands; Technical University Munich, Klinikum rechts der Isar, Department of Nuclear Medicine, Munich, Germany.
Gerritsen WR; Radboud University Medical Center, Department of Medical Oncology, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
Urologic oncology [Urol Oncol] 2020 Dec 19. Date of Electronic Publication: 2020 Dec 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prior PSMA PET-CT Imaging and Hounsfield Unit Impact on Tumor Yield and Success of Molecular Analyses from Bone Biopsies in Metastatic Prostate Cancer.
Autorzy :
Smits M; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Ekici K; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Pamidimarri Naga S; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Sedelaar MJP; Department of Urology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Schalken JA; Department of Urology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.; Department of Nuclear Medicine, Technical University, Arcisstraße 21, 80333 Munich, Germany.
Scheenen TWJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Fütterer JJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
Cancers [Cancers (Basel)] 2020 Dec 14; Vol. 12 (12). Date of Electronic Publication: 2020 Dec 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Optimal F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer.
Autorzy :
Draulans C; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium. .; Department of Oncology, KU Leuven, Leuven, Belgium. .
De Roover R; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.
van der Heide UA; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Kerkmeijer L; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Department of Radiation Oncology, University Medical Centre, Utrecht, The Netherlands.
Smeenk RJ; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Pos F; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Vogel WV; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Nagarajah J; Department of Radiology & Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
Janssen M; Department of Radiology & Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
Isebaert S; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.
Maes F; Department of Electrical Engineering, ESAT/PSI, KU Leuven, Leuven, Belgium.; Medical Imaging Research Centre, University Hospitals Leuven, Leuven, Belgium.
Mai C; Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
Oyen R; Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
Joniau S; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Kunze-Busch M; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Goffin K; Department of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium.
Haustermans K; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium. .; Department of Oncology, KU Leuven, Leuven, Belgium. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2020 Oct 06. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology.
Autorzy :
Privé BM; Department of Radiology & Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. .
Israël B; Department of Radiology & Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Schilham MGM; Department of Radiology & Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Muselaers CHJ; Department of Urology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Zámecnik P; Department of Radiology & Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Mulders PFA; Department of Urology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Witjes JA; Department of Urology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Sedelaar M; Department of Urology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Verzijlbergen F; Department of Radiology & Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Janssen MJR; Department of Radiology & Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Gotthardt M; Department of Radiology & Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Barentsz JO; Department of Radiology & Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Nagarajah J; Department of Radiology & Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2020 Sep 30. Date of Electronic Publication: 2020 Sep 30.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy.
Autorzy :
Dotinga M; Section of Nuclear Medicine, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands - .
Vriens D; Section of Nuclear Medicine, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
van Velden F; Section of Nuclear Medicine, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
Heijmen L; Section of Nuclear Medicine, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Nuclear Medicine, Technical University Munich, Munich, Germany.
Hicks R; Department of Molecular Imaging, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.
Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
de Geus-Oei LF; Section of Nuclear Medicine, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.; Biomedical Photonic Imaging Group, University of Twente, Enschede, the Netherlands.
Pokaż więcej
Źródło :
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. [Q J Nucl Med Mol Imaging] 2020 Sep; Vol. 64 (3), pp. 250-264.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
68Ga-Prostate-Specific Membrane Antigen-11-Avid Cardiac Metastases in a Patient With Adenoid Cystic Carcinoma, A Rare Presentation of a Rare Cancer.
Autorzy :
Uijen MJM; From the Department of Medical Oncology, Radboud Institute for Health Sciences.
van Boxtel W; From the Department of Medical Oncology, Radboud Institute for Health Sciences.
van Herpen CML; From the Department of Medical Oncology, Radboud Institute for Health Sciences.
Gotthardt M; Department of Radiology, Nuclear Medicine and Anatomy, Radboud University Medical Center, Nijmegen, the Netherlands.
Nagarajah J
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2020 Sep; Vol. 45 (9), pp. 716-718.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Oligopeptides*
Positron Emission Tomography Computed Tomography*
Carcinoma, Adenoid Cystic/*pathology
Edetic Acid/*analogs & derivatives
Heart Neoplasms/*diagnostic imaging
Heart Neoplasms/*secondary
Aged ; Humans ; Male
Czasopismo naukowe
Tytuł :
Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study.
Autorzy :
van Boxtel W; Department of Medical Oncology, Radboud university medical center, Nijmegen, the Netherlands.
Lütje S; Department of Radiology and Nuclear Medicine, Radboud university medical center, Nijmegen, the Netherlands.; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
van Engen-van Grunsven ICH; Department of Pathology, Radboud university medical center, Nijmegen, the Netherlands.
Verhaegh GW; Department of Urology, Radboud university medical center, Nijmegen, the Netherlands.
Schalken JA; Department of Urology, Radboud university medical center, Nijmegen, the Netherlands.
Jonker MA; Department of Health Evidence, Radboud university medical center, Nijmegen, the Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud university medical center, Nijmegen, the Netherlands.; Department of Nuclear Medicine, Technical University Munich, Germany.
Gotthardt M; Department of Radiology and Nuclear Medicine, Radboud university medical center, Nijmegen, the Netherlands.
van Herpen CML; Department of Medical Oncology, Radboud university medical center, Nijmegen, the Netherlands.
Pokaż więcej
Źródło :
Theranostics [Theranostics] 2020 Jan 12; Vol. 10 (5), pp. 2273-2283. Date of Electronic Publication: 2020 Jan 12 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Ga-PSMA-PET/CT and Diffusion MRI Targeting for Cone-Beam CT-Guided Bone Biopsies of Castration-Resistant Prostate Cancer Patients.
Autorzy :
van Steenbergen TRF; Department of Radiology and Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. .
Smits M; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Scheenen TWJ; Department of Radiology and Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Rovers MM; Department of Operating Rooms, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Fütterer JJ; Department of Radiology and Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
Cardiovascular and interventional radiology [Cardiovasc Intervent Radiol] 2020 Jan; Vol. 43 (1), pp. 147-154. Date of Electronic Publication: 2019 Aug 23.
Typ publikacji :
Journal Article
MeSH Terms :
Oligopeptides*
Bone Neoplasms/*pathology
Cone-Beam Computed Tomography/*methods
Diffusion Magnetic Resonance Imaging/*methods
Edetic Acid/*analogs & derivatives
Positron Emission Tomography Computed Tomography/*methods
Prostatic Neoplasms, Castration-Resistant/*pathology
Aged ; Bone Neoplasms/diagnostic imaging ; Bone Neoplasms/secondary ; Bone and Bones/diagnostic imaging ; Bone and Bones/pathology ; Humans ; Image-Guided Biopsy ; Male ; Middle Aged ; Pilot Projects ; Prospective Studies ; Radiography, Interventional/methods ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer.
Autorzy :
Weber M; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany.
Binse I; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany.
Nagarajah J; Department of Radiology and Nuclear Medicine, Nijmegen, the Netherlands.; Department of Nuclear Medicine, University Hospital rechts der Isar, Technical University of Munich, Munich, Germany.
Bockisch A; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany.
Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany.
Jentzen W; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany - .
Pokaż więcej
Źródło :
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. [Q J Nucl Med Mol Imaging] 2019 Sep; Vol. 63 (3), pp. 235-252. Date of Electronic Publication: 2019 Jul 11.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Iodine Radioisotopes*
Positron Emission Tomography Computed Tomography/*methods
Thyroid Neoplasms/*diagnostic imaging
Humans ; Radiometry ; Thyroid Neoplasms/pathology
Czasopismo naukowe
Tytuł :
EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC.
Autorzy :
Krishnamoorthy GP; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Davidson NR; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Leach SD; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Zhao Z; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Lowe SW; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Lee G; Department of Pharmacology, Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
Landa I; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Nagarajah J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Saqcena M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Singh K; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Wendel HG; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Dogan S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Tamarapu PP; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Blenis J; Department of Pharmacology, Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
Ghossein RA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Knauf JA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Rätsch G; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Fagin JA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. .; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Pokaż więcej
Źródło :
Cancer discovery [Cancer Discov] 2019 Feb; Vol. 9 (2), pp. 264-281. Date of Electronic Publication: 2018 Oct 10.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Alternative Splicing*
Mutation*
Activating Transcription Factor 4/*metabolism
Carcinogenesis/*pathology
Eukaryotic Initiation Factor-1/*genetics
Thyroid Neoplasms/*pathology
ras Proteins/*genetics
Activating Transcription Factor 4/genetics ; Animals ; Apoptosis ; Carcinogenesis/drug effects ; Carcinogenesis/genetics ; Carcinogenesis/metabolism ; Cell Proliferation ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Phosphorylation ; Protein Biosynthesis ; Protein Kinase Inhibitors/pharmacology ; TOR Serine-Threonine Kinases/genetics ; TOR Serine-Threonine Kinases/metabolism ; Thyroid Neoplasms/drug therapy ; Thyroid Neoplasms/genetics ; Thyroid Neoplasms/metabolism ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Current Treatment Strategies in Metastasized Differentiated Thyroid Cancer.
Autorzy :
Kreissl MC; Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Magdeburg, Germany.
Janssen MJR; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; and.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; and james.nagarajah@radboudumc.nl.; Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.
Pokaż więcej
Źródło :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2019 Jan; Vol. 60 (1), pp. 9-15. Date of Electronic Publication: 2018 Sep 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Thyroid Neoplasms/*pathology
Thyroid Neoplasms/*therapy
Cell Differentiation/drug effects ; Humans ; Molecular Targeted Therapy/adverse effects ; Neoplasm Metastasis ; Thyroid Neoplasms/drug therapy ; Thyroid Neoplasms/radiotherapy
Czasopismo naukowe
Tytuł :
Quantitative performance of I PET/CT as reference.
Autorzy :
Jentzen W; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Phaosricharoen J; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Gomez B; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Hetkamp P; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Stebner V; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Binse I; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Kinner S; Department of Radiology, University of Duisburg-Essen, Essen, Germany.
Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Sabet A; Department of Nuclear Medicine, University Hospital Frankfurt, Frankfurt, Germany.
Nagarajah J; Department of Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany. james.nagarajah@uk-essen.de.; Radboudumc, Department of Radiology and Nuclear Medicine, Nijmegen, The Netherlands. james.nagarajah@uk-essen.de.
Pokaż więcej
Źródło :
EJNMMI physics [EJNMMI Phys] 2018 Jul 19; Vol. 5 (1), pp. 13. Date of Electronic Publication: 2018 Jul 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics of 131I in patients with differentiated thyroid carcinoma receiving high therapeutic activities.
Autorzy :
Ruhlmann M; Department of Nuclear Medicine, University Hospital, University of Duisburg-Essen, Essen.; Department of Diagnostic and Interventional Radiology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany.
Sonnenschein W; Department of Nuclear Medicine, University Hospital, University of Duisburg-Essen, Essen.
Nagarajah J; Department of Nuclear Medicine, University Hospital, University of Duisburg-Essen, Essen.; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Binse I; Department of Nuclear Medicine, University Hospital, University of Duisburg-Essen, Essen.
Herrmann K; Department of Nuclear Medicine, University Hospital, University of Duisburg-Essen, Essen.
Jentzen W; Department of Nuclear Medicine, University Hospital, University of Duisburg-Essen, Essen.
Pokaż więcej
Źródło :
Nuclear medicine communications [Nucl Med Commun] 2018 May; Vol. 39 (5), pp. 457-464.
Typ publikacji :
Journal Article
MeSH Terms :
Iodine Radioisotopes/*blood
Iodine Radioisotopes/*therapeutic use
Thyroid Neoplasms/*blood
Thyroid Neoplasms/*radiotherapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Kinetics ; Male ; Middle Aged ; Radiometry ; Radiotherapy Dosage ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer.
Autorzy :
Tesselaar MH; Department of Pathology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Crezee T; Department of Pathology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Schuurmans I; Department of Pathology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Gerrits D; Department of Radiology and Nuclear Medicine, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands; and.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands; and.
Boerman OC; Department of Radiology and Nuclear Medicine, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands; and.
van Engen-van Grunsven I; Department of Pathology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Smit JWA; Department of Internal Medicine, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Netea-Maier RT; Department of Internal Medicine, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Plantinga TS; Department of Pathology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands .
Pokaż więcej
Źródło :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2018 May; Vol. 59 (5), pp. 780-786. Date of Electronic Publication: 2017 Dec 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Digitalis/*chemistry
Iodides/*metabolism
Symporters/*metabolism
Thyroid Carcinoma, Anaplastic/*drug therapy
Thyroid Carcinoma, Anaplastic/*metabolism
Activating Transcription Factor 3/metabolism ; Adenocarcinoma, Follicular/drug therapy ; Adenocarcinoma, Follicular/metabolism ; Autophagy ; Cell Cycle ; Cell Differentiation ; Cell Line, Tumor ; Cell Proliferation ; Gene Expression Profiling ; Humans ; Iodine Radioisotopes ; Microscopy, Fluorescence ; Polymerase Chain Reaction ; Proto-Oncogene Proteins c-fos/metabolism ; Thyroglobulin/metabolism ; Thyroid Neoplasms/drug therapy ; Thyroid Neoplasms/metabolism
SCR Disease Name :
Thyroid cancer, follicular
Czasopismo naukowe
Tytuł :
[Somatostatin receptor PET/CT (SSTR-PET/CT)].
Autorzy :
Boy C
Poeppel T
Kotzerke J
Krause BJ
Amthauer H
Baum RP
Buchmann I
Ezziddin S
Führer D
Gabriel M
Kuwert T
Lahner H
Lauenstein T
Maecke HR
Nagarajah J
Rösch F
Scheidhauer K
Schmidt M
Walter MA
Bockisch A
Pokaż więcej
Transliterated Title :
Somatostatinrezeptor-PET/CT.
Źródło :
Nuklearmedizin. Nuclear medicine [Nuklearmedizin] 2018 Feb; Vol. 57 (1), pp. 4-17. Date of Electronic Publication: 2018 Feb 21.
Typ publikacji :
Journal Article
MeSH Terms :
Positron Emission Tomography Computed Tomography*
Practice Guidelines as Topic*
Receptors, Somatostatin/*metabolism
Humans ; Neoplasms/diagnostic imaging ; Neoplasms/metabolism ; Radiopharmaceuticals
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies